Haydar Bulut

1.7k total citations
28 papers, 915 citations indexed

About

Haydar Bulut is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Haydar Bulut has authored 28 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Virology. Recurrent topics in Haydar Bulut's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Haydar Bulut is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Haydar Bulut collaborates with scholars based in United States, Japan and Germany. Haydar Bulut's co-authors include Wolfram Saenger, Volker Haucke, Mark J. Robertson, Kylie A. MacGregor, Kira V. Gromova, Dmytro Puchkov, Hans‐Georg Kräusslich, N.V. Tomilin, Ngoc Chau and Hiroaki Mitsuya and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Haydar Bulut

27 papers receiving 903 citations

Peers

Haydar Bulut
Deepak Sharma United States
Jessie J. Guidry United States
Liangzhong Lim Singapore
Ruo Xu United States
Haydar Bulut
Citations per year, relative to Haydar Bulut Haydar Bulut (= 1×) peers Isabelle Huvent

Countries citing papers authored by Haydar Bulut

Since Specialization
Citations

This map shows the geographic impact of Haydar Bulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haydar Bulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haydar Bulut more than expected).

Fields of papers citing papers by Haydar Bulut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haydar Bulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haydar Bulut. The network helps show where Haydar Bulut may publish in the future.

Co-authorship network of co-authors of Haydar Bulut

This figure shows the co-authorship network connecting the top 25 collaborators of Haydar Bulut. A scholar is included among the top collaborators of Haydar Bulut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haydar Bulut. Haydar Bulut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohnuki, Hidetaka, Stewart R. Durell, Haydar Bulut, et al.. (2025). Angiopoietin-2 binds to FGFR2, inhibits FGF-FGFR2 signaling, and delays cutaneous wound healing by inhibiting wound angiogenesis. Angiogenesis. 28(4). 43–43. 2 indexed citations
2.
Krauß, M., Haydar Bulut, Valérie Chambon, et al.. (2025). Next-generation small molecule inhibitors of clathrin function acutely inhibit endocytosis. Structure. 33(5). 878–890.e7. 2 indexed citations
3.
Hattori, Shin-ichiro, Haydar Bulut, Hironori Hayashi, et al.. (2024). Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2. Proceedings of the National Academy of Sciences. 121(37). e2404175121–e2404175121. 7 indexed citations
4.
Davis, David A., Ashwin Nair, Brian D. Peyser, et al.. (2024). Discovery of a nasal spray steroid, tixocortol, as an inhibitor of SARS-CoV-2 main protease and viral replication. RSC Medicinal Chemistry. 15(12). 4193–4205.
5.
Tsuji, Kohei, Takuya Kobayakawa, Takahiro Ishii, et al.. (2023). Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical and Pharmaceutical Bulletin. 71(12). 879–886. 3 indexed citations
6.
Kumamoto, Hiroki, Nobuyo Higashi‐Kuwata, Sanae Hayashi, et al.. (2023). Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent. RSC Advances. 13(23). 15999–16011. 2 indexed citations
7.
Bulut, Haydar. (2022). Drug development targeting SARS-CoV-2 main protease. Global Health & Medicine. 4(6). 296–300. 1 indexed citations
8.
Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Hiroki Kumamoto, et al.. (2020). Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV. Journal of Hepatology. 74(5). 1075–1086. 21 indexed citations
9.
Bulut, Haydar, Shin‐ichiro Hattori, Hironori Hayashi, et al.. (2020). Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity. Scientific Reports. 10(1). 10664–10664. 70 indexed citations
10.
Amano, Masayuki, Haydar Bulut, Sadahiro Tamiya, et al.. (2019). Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition. Scientific Reports. 9(1). 9806–9806. 4 indexed citations
11.
12.
Eşrefoğlu, Mukaddes, Olgu Enis Tok, Şahabettin Selek, et al.. (2018). Protection with thymoquinone against formaldehyde-induced neurotoxicity in the rats. Bratislavské lekárske listy/Bratislava medical journal. 119(11). 726–730. 5 indexed citations
13.
Jung, Sangyong, Tanja Maritzen, Carolin Wichmann, et al.. (2015). Disruption of adaptor protein 2μ ( AP ‐2μ) in cochlear hair cells impairs vesicle reloading of synaptic release sites and hearing. The EMBO Journal. 34(21). 2686–2702. 75 indexed citations
14.
Bulut, Haydar, Qingjun Ma, S. Moniot, et al.. (2012). Crystal structures of receptors involved in small molecule transport across membranes. European Journal of Cell Biology. 91(4). 318–325. 5 indexed citations
15.
Kleist, Lisa von, Wiebke Stahlschmidt, Haydar Bulut, et al.. (2011). Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition. Cell. 146(5). 841–841. 6 indexed citations
16.
Kleist, Lisa von, Wiebke Stahlschmidt, Haydar Bulut, et al.. (2011). Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition. Cell. 146(3). 471–484. 428 indexed citations
17.
Bulut, Haydar, Sibel Alper, Hüseyin Önay, et al.. (2011). Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population. Genetics and Molecular Research. 10(4). 4126–4132. 16 indexed citations
18.
Bulut, Haydar, S. Moniot, Anke Licht, et al.. (2011). Crystal Structures of Two Solute Receptors for l-Cystine and l-Cysteine, Respectively, of the Human Pathogen Neisseria gonorrhoeae. Journal of Molecular Biology. 415(3). 560–572. 34 indexed citations
19.
Licht, Anke, Haydar Bulut, F. Scheffel, et al.. (2010). Crystal Structures of the Bacterial Solute Receptor AcbH Displaying an Exclusive Substrate Preference for β-d-Galactopyranose. Journal of Molecular Biology. 406(1). 92–105. 21 indexed citations
20.
Vahedi‐Faridi, Ardeschir, Anke Licht, Haydar Bulut, et al.. (2010). Crystal Structures of the Solute Receptor GacH of Streptomyces glaucescens in Complex with Acarbose and an Acarbose Homolog: Comparison with the Acarbose-Loaded Maltose-Binding Protein of Salmonella typhimurium. Journal of Molecular Biology. 397(3). 709–723. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026